参考文献:1. Desquilbet, L, Jacobson, L, Fried, LP, Phair, JP, Williams, CM, Jamieson, BD (2007) HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 62: pp. 1279-86 CrossRef 2. Piggott, DA, Muzaale, AD, Mehta, SH, Brown, TT, Patel, KV, Leng, SX (2013) Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE 8: pp. e54910 CrossRef 3. Desquilbet, L, Margolick, JB, Fried, LP, Phair, JP, Jamieson, BD, Holloway, M (2009) Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-1 infected men. J Acquir Immun Defic Syndr 50: pp. 299-306 CrossRef 4. Terzian, AS, Holman, S, Nathwani, N, Robison, E, Weber, K, Young, M (2009) Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt) 18: pp. 1965-74 CrossRef 5. Pathai, S, Gilbert, C, Weiss, HA, Cook, C, Wood, R, Bekker, LG (2013) Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 62: pp. 43-51 CrossRef 6. Akg眉n, KM, Tate, JP, Crothers, K, Crystal, S, Leaf, DA, Womack, J (2014) An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. JAIDS 67: pp. 397-404 7. Fried, L, Tangen, CM, Walston, J, Newman, AB, Hirsch, C, Gottdiener, J (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci 56A: pp. M146-56 CrossRef 8. Bandeen-Roche, K, Xue, QL, Ferrucci, L, Walston, J, Guralnik, JM, Chaves, P (2006) Phenotype of frailty: characterization in the women鈥檚 health and aging studies. J Gerontol A Biol Sci Med Sci 61: pp. 262-6 CrossRef 9. Lipsitz, LA (2002) Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol A Biol Sci Med Sci 57: pp. B115-25 CrossRef 10. Fried, LP, Hadley, EC, Walston, JD, Newman, AB, Guralnik, JM, Studenski, S (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 2005: pp. e24 CrossRef 11. Walston, J, Hadley, EC, Ferrucci, L, Guralnik, JM, Newman, AB, Studenski, SA (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54: pp. 991-1001 CrossRef 12. Yao, X, Li, H, Leng, SX (2011) Inflammation and immune system alterations in frailty. Clin Geriatr Med 27: pp. 79-87 CrossRef 13. Chen, X, Mao, G, Leng, SX (2014) Frailty syndrome: an overview. Clin Interv Aging 9: pp. 433-41 14. Morley, JE, Vellas, B, Kan, GA, Anker, SD, Bauer, JM, Bernabei, R (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14: pp. 392-7 CrossRef 15. Fried, LP, Xue, QL, Cappola, AR, Ferrucci, L, Chaves, P, Varadhan, R (2009) Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 64: pp. 1049-57 CrossRef 16. Jones, DM, Song, X, Rockwood, K (2004) Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc 52: pp. 1929-33 CrossRef 17. Brothers, TD, Kirkland, S, Guaraldi, G, Falutz, J, Theou, O, Johnston, BL (2014) Frailty in people aging with human immunodeficiency virus (HIV) infection. J Infect Dis 210: pp. 1170-9 CrossRef 18. Fried, LP, Ferrucci, L, Darer, J, Williamson, JD, Anderson, G (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59: pp. 255-63 CrossRef 19. Santos-Eggimann, B, Cuenoud, P, Spagnoli, J, Junod, J (2009) Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 64: pp. 675-81 CrossRef 20. Alvarado, BE, Zunzunegui, MV, Beland, F, Bamvita, JM (2008) Life course social and health conditions linked to frailty in Latin American older men and women. J Gerontol A Biol Sci Med Sci 63: pp. 1399-406 CrossRef 21. Buchman, AS, Boyle, PA, Wilson, RS, Tang, Y, Bennett, DA (2007) Frailty is associated with incident Alzheimer鈥檚 disease and cognitive decline in the elderly. Psychosom Med 69: pp. 483-9 CrossRef 22. Makary, MA, Segev, DL, Pronovost, PJ, Syin, D, Bandeen-Roche, K, Patel, P (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210: pp. 901-8 CrossRef 23. Ronning, B, Wyller, TB, Seljeflot, I, Jordhoy, MS, Skovlund, E, Nesbakken, A (2010) Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients. Age Ageing 39: pp. 758-61 CrossRef 24. Audisio, RA, Leeuwen, B (2011) When reporting on older patients with cancer, frailty information is needed. Ann Surg Oncol 18: pp. 4-5 CrossRef 25. Courtney-Brooks, M, Tellawi, AR, Scalici, J, Duska, LR, Jazaeri, AA, Modesitt, SC (2012) Frailty: an outcome predictor for elderly gynecologic oncology patients. Gynecol Oncol 126: pp. 20-4 CrossRef 26. Aaldriks, AA, Geest, LG, Giltay, EJ, Cessie, S, Portielje, JE, Tanis, BC (2013) Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 4: pp. 218-26 CrossRef 27. Iqbal, J, Denvir, M, Gunn, J (2013) Frailty assessment in elderly people. Lancet 381: pp. 1985-6 CrossRef 28. McAdams-DeMarco, MA, Suresh, S, Law, A, Salter, ML, Gimenez, LF, Jaar, BG (2013) Frailty and falls among adult patients undergoing chronic hemodialysis: a prospective cohort study. BMC Nephrol 14: pp. 224 CrossRef 29. McAdams-DeMarco MA, Law A, Tan J, Delp C, King EA, Orandi B et al. Frailty, Mycophenolate Reduction, and Graft Loss in Kidney Transplant Recipients. Transplantation 2014 30. Yao, X, Hamilton, RG, Weng, NP, Xue, QL, Bream, JH, Li, H (2011) Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 29: pp. 5015-21 CrossRef 31. Ridda, I, Macintyre, CR, Lindley, R, Gao, Z, Sullivan, JS, Yuan, FF (2009) Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27: pp. 1628-36 CrossRef 32. Fahey, JL, Taylor, JMG, Detels, R, Hofmann, B, Melmed, R, Nishanian, P (1990) The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322: pp. 166-72 CrossRef 33. Lahdevirta, J, Maury, CPJ, Teppo, A-M, Repo, H (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85: pp. 289-91 CrossRef 34. Palella, FJ, Delaney, KM, Moorman, AC, Loveless, MO, Fuhrer, J, Satten, GA (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. NEJM 338: pp. 853-60 CrossRef 35. Liu, H, Lin, X, Xu, Y, Chen, S, Shi, J, Morisky, D (2012) Emerging HIV epidemic among older adults in Nanning China. AIDS Patient Care STDS 26: pp. 565-7 CrossRef 36. Hontelez, JA, Lurie, MN, Newell, ML, Bakker, R, Tanser, F, Barnighausen, T (2011) Ageing with HIV in South Africa. AIDS 25: pp. 1665-7 CrossRef 37. High, KP, Brennan-Ing, M, Clifford, DB, Cohen, MH, Currier, J, Deeks, SG (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 60: pp. S1-18 CrossRef 38. Guaraldi, G, Orlando, G, Zona, S, Menozzi, M, Carli, F, Garlassi, E (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53: pp. 1120-6 CrossRef 39. Deeks, SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: pp. 141-55 CrossRef 40. Desquilbet L, Jacobson L, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011;66A:1030鈥?. / This paper provides evidene that a frailty-related phenotype independently predicted onset of AIDS or death in a cohort of men who have sex with men. 41. Althoff, KN, Jacobson, LP, Cranston, RD, Detels, R, Phair, JP, Li, X (2014) Age, comorbidities and AIDS predict the frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 69A: pp. 189-98 CrossRef 42. Green M, Covinsky K, Astemborski J, Piggot D, Brown T, Leng S et al. The relationship of physical performance with HIV disease and mortality. AIDS 2014; 28. 43. Onen, NF, Agbebi, A, Shacham, E, Stamm, KE, Onen, AR, Overton, ET (2009) Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 59: pp. 346-52 CrossRef 44. Franceschi, C, Bonafe, M, Valensin, S, Olivieri, F, De, LM, Ottaviani, E (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: pp. 244-54 CrossRef 45. Martinis, M, Franceschi, C, Monti, D, Ginaldi, L (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80: pp. 219-27 CrossRef 46. Roubenoff, R, Parise, H, Payette, HA, Abad, LW, D鈥橝gostino, R, Jacques, PF (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 115: pp. 429-35 CrossRef 47. Leng, S, Chaves, P, Koenig, K, Walston, J (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50: pp. 1268-71 CrossRef 48. Walston, J, McBurnie, MA, Newman, A, Tracy, RP, Kop, WJ, Hirsch, CH (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162: pp. 2333-41 CrossRef 49. Schmaltz, HN, Fried, LP, Xue, QL, Walston, J, Leng, SX, Semba, RD (2005) Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 53: pp. 747-54 CrossRef 50. Leng, SX, Xue, QL, Tian, J, Walston, JD, Fried, LP (2007) Inflammation and frailty in older women. J Am Geriatr Soc 55: pp. 864-71 CrossRef 51. Hubbard, RE, O鈥橫ahony, MS, Savva, GM, Calver, BL, Woodhouse, KW (2009) Inflammation and frailty measures in older people. J Cell Mol Med 13: pp. 3103-9 CrossRef 52. Collerton, J, Martin-Ruiz, C, Davies, K, Hilkens, CM, Isaacs, J, Kolenda, C (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 133: pp. 456-66 CrossRef 53. Leng, SX, Xue, QL, Tian, J, Huang, Y, Yeh, SH, Fried, LP (2009) Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women鈥檚 Health and Aging Studies I. Exp Gerontol 44: pp. 511-6 CrossRef 54. Semba, RD, Margolick, JB, Leng, S, Walston, J, Ricks, MO, Fried, LP (2005) T cell subsets and mortality in older community-dwelling women. Exp Gerontol 40: pp. 81-7 CrossRef 55. Fanis, U, Wang, GC, Fedarko, NS, Walston, JD, Casolaro, V, Leng, SX (2008) T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc 56: pp. 904-8 CrossRef 56. Loetscher, P, Uguccioni, M, Bordoli, L, Baggiolini, M, Moser, B, Chizzolini, C (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391: pp. 344-5 CrossRef 57. Leng, SX, Yang, H, Walston, JD (2004) Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clin Exp Res 16: pp. 249-52 CrossRef 58. Qu, T, Walston, JD, Yang, H, Fedarko, NS, Xue, QL, Beamer, BA (2009) Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults. Mech Ageing Dev 130: pp. 161-6 CrossRef 59. Qu, T, Yang, H, Walston, JD, Fedarko, NS, Leng, SX (2009) Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine 46: pp. 319-24 CrossRef 60. Leng, SX, Tian, X, Matteini, A, Li, H, Hughes, J, Jain, A (2011) IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 40: pp. 475-81 CrossRef 61. Ferrucci, L, Penninx, BW, Volpato, S, Harris, TB, Bandeen-Roche, K, Balfour, J (2002) Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50: pp. 1947-54 CrossRef 62. Maggio, M, Guralnik, JM, Longo, DL, Ferrucci, L (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61: pp. 575-84 CrossRef 63. Chaves, PH, Semba, RD, Leng, SX, Woodman, RC, Ferrucci, L, Guralnik, JM (2005) Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women鈥檚 Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 60: pp. 729-35 CrossRef 64. Leng, SX, Cappola, AR, Andersen, RE, Blackman, MR, Koenig, K, Blair, M (2004) Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16: pp. 153-7 CrossRef 65. Leng, SX, Hung, W, Cappola, AR, Yu, Q, Xue, QL, Fried, LP (2009) White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J Gerontol A Biol Sci Med Sci 64: pp. 499-502 CrossRef 66. Lederman, MM, Funderburg, NT, Sekaly, RP, Klatt, NR, Hunt, PW (2013) Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol 119: pp. 51-83 CrossRef 67. Regidor, DL, Detels, R, Breen, EC, Widney, DP, Jacobson, LP, Palella, F (2011) Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 25: pp. 303-14 CrossRef 68. Martin, J, Volberding, P (2010) HIV and premature aging: a field still in its infancy. Ann Intern Med 153: pp. 477-9 CrossRef 69. Shiels, MS, Pfeiffer, RM, Engels, EA (2010) Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 153: pp. 452-60 CrossRef 70. Erlandson, KM, Allshouse, AA, Jankowski, CM, Lee, EJ, Rufner, KM, Palmer, BE (2013) Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 208: pp. 249-59 CrossRef 71. Justice, AC, Freiberg, MS, Tracy, R, Kuller, L, Tate, JP, Goetz, MB (2012) Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis 54: pp. 984-94 CrossRef 72. Womack, JA, Goulet, JL, Gibert, C, Brandt, CA, Skanderson, M, Gulanski, B (2013) Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis 56: pp. 1498-504 CrossRef 73. Wada NI, Jacobson LP, Margolick JB, Breen EB, Macatangay B, Penugonda S et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. In press. / This paper shows the magnitude and time course of effects of HIV suppression on systemic inflammation. 74. Margolick JB, Martinez-Maza O, Jacobson L, Lopez J, Li X, Phair J et al. Frailty and circulating markers of inflammation in HIV-infected and -uninfected men in the Multicenter AIDS Cohort Study (MACS). Presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, March 2013, Abstract #800 . 2013. Ref Type: Abstract 75. Looney, RJ, Falsey, A, CAMPBELL, D, Torres, A, Kolassa, J, Brower, C (1999) Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 90: pp. 213-9 CrossRef 76. Olsson, J, Wikby, A, Johansson, B, Lofgren, S, Nilsson, BO, Ferguson, FG (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: pp. 187-201 77. Pawelec, G, Akbar, A, Caruso, C, Solana, R, Grubeck-Loebenstein, B, Wikby, A (2005) Human immunosenescence: is it infectious?. Immunol Rev 205: pp. 257-68 CrossRef 78. Khan, N, Shariff, N, Cobbold, M, Bruton, R, Ainsworth, JA, Sinclair, AJ (2002) Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169: pp. 1984-92 CrossRef 79. Koch, S, Larbi, A, Ozcelik, D, Solana, R, Gouttefangeas, C, Attig, S (2007) Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 1114: pp. 23-35 CrossRef 80. Sylwester, AW, Mitchell, BL, Edgar, JB, Taormina, C, Pelte, C, Ruchti, F (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202: pp. 673-85 CrossRef 81. Naeger, DM, Martin, JN, Sinclair, E, Hunt, PW, Bangsberg, DR, Hecht, F (2010) Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One 5: pp. e8886 CrossRef 82. Li, H, Margolick, JB, Bream, JH, Nilles, TL, Langan, S, Bui, HT (2014) Heterogeneity of CD4+ and CD8+ T-cell responses of cytomegalovirus in HIV-infected and -uninfected men who have sex with men. J Infect Dis 210: pp. 400-4 CrossRef 83. Wang, GC, Kao, WH, Murakami, P, Xue, QL, Chiou, RB, Detrick, B (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 171: pp. 1144-52 CrossRef 84. Mathei, C, Vaes, B, Wallemacq, P, Degryse, J (2011) Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc 59: pp. 2201-8 CrossRef 85. Vallejo, AN, Hamel, DL, Mueller, RG, Ives, DG, Michel, JJ, Boudreau, RM (2011) NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS ONE 6: pp. e26558 CrossRef 86. Leng, SX, Qu, T, Semba, RD, Yao, X, Nilles, T, Yang, X (2011) Relationship between cytomegalovirus (CMV) IgG seropositivity, detectable CMV DNA peripheral monocytes, and CMV-specific CD8+ T-cells in older adults. Age (Dordr) 33: pp. 607-14 CrossRef 87. Leng, SX, Li, H, Xue, QL, Tian, J, Yang, X, Ferrucci, L (2011) Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults. Exp Gerontol 46: pp. 679-84 88. Li, H, Weng, P, Najarro, K, Xue, Q-L, Semba, RD, Margolick, JB (2013) Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp 65 (NLV)-specific CD8+ T-cell frequencies with twelve year follow-up. Exp Gerontol 54: pp. 84-9 CrossRef 89. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a Model of Accelerated or Accentuated Aging? J Gerontol A Biol Sci Med Sci. 2013. 90. Barrett, L, Fowke, KR, Grant, MD (2012) Cytomegalovirus, aging, and HIV: a perfect storm. AIDS Rev 14: pp. 159-67 91. Hunt, PW, Martin, JN, Sinclair, E, Epling, L, Teague, J, Jacobson, MA (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203: pp. 1474-83 CrossRef 92. Pass, RF, Zhang, C, Evans, A, Simpson, T, Andrews, W, Huang, ML (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360: pp. 1191-9 CrossRef 93. Griffiths, PD, Stanton, A, McCarrell, E, Smith, C, Osman, M, Harber, M (2011) Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377: pp. 1256-63 CrossRef 94. Sabbaj, S, Pass, RF, Goepfert, PA, Pichon, S (2011) Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 203: pp. 1534-41 CrossRef 95. Kharfan-Dabaja, MA, Boeckh, M, Wilck, MB, Langston, AA, Chu, AH, Wloch, MK (2012) A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12: pp. 290-9 CrossRef
刊物主题:Medicine/Public Health, general;
出版者:Springer US
ISSN:1548-3576
文摘
Frailty is a clinical syndrome initially characterized in geriatric populations with a hallmark of age-related declines in physiologic reserve and function and increased vulnerability to adverse health outcomes. Recently, frailty has increasingly been recognized as a common and important HIV-associated non-AIDS (HANA) condition. This article provides an overview of our current understanding of frailty and its phenotypic characteristics and evidence that they are related to aging and to chronic inflammation that is associated with aging and also with long-term treated HIV infection. The etiology of this chronic inflammation is unknown but we discuss evidence linking it to persistent infection with cytomegalovirus in both geriatric populations and people living with HIV infection.